PGD for BRCA mutations

Preimplantation Genetic Diagnosis (PGD) for BRCA mutations involves testing embryos created through IVF for the presence of BRCA gene mutations, which increase breast and ovarian cancer risk. Before implantation, embryos are screened so only those without the mutation are selected for transfer, allowing prospective parents to reduce the likelihood of passing the genetic risk to their children. This process provides informed reproductive choices for individuals with BRCA mutations, helping them prevent passing on the increased cancer risk while maintaining the option to have biological children.